Total Payments
$74,561
2024 Payments
$650.00
Companies
7
Transactions
171
Medicare Patients
1,169
Medicare Billing
$179,551
Payment Breakdown by Category
Other$59,925 (80.4%)
Travel$9,456 (12.7%)
Food & Beverage$3,477 (4.7%)
Consulting$1,685 (2.3%)
Education$18.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $59,925 | 35 | 80.4% |
| Travel and Lodging | $9,456 | 72 | 12.7% |
| Food and Beverage | $3,477 | 62 | 4.7% |
| Consulting Fee | $1,685 | 1 | 2.3% |
| Education | $18.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $53,679 | 107 | $0 (2022) |
| BioXcel Therapeutics, Inc. | $20,396 | 59 | $0 (2024) |
| CSL Behring | $111.70 | 1 | $0 (2018) |
| Covidien LP | $110.76 | 1 | $0 (2018) |
| Getinge USA Sales, LLC | $108.79 | 1 | $0 (2023) |
| PFIZER INC. | $99.02 | 1 | $0 (2019) |
| ABBVIE INC. | $55.05 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $650.00 | 1 | BioXcel Therapeutics, Inc. ($650.00) |
| 2023 | $19,910 | 60 | BioXcel Therapeutics, Inc. ($19,746) |
| 2022 | $2,185 | 3 | AstraZeneca Pharmaceuticals LP ($2,185) |
| 2021 | $45,692 | 91 | AstraZeneca Pharmaceuticals LP ($45,692) |
| 2020 | $5,802 | 13 | AstraZeneca Pharmaceuticals LP ($5,802) |
| 2019 | $99.02 | 1 | PFIZER INC. ($99.02) |
| 2018 | $222.46 | 2 | CSL Behring ($111.70) |
All Payment Transactions
171 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/13/2024 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $55.05 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/31/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $9.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $83.81 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2023 | Getinge USA Sales, LLC | Cardiohelp (Device) | Food and Beverage | In-kind items and services | $108.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/31/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,137.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $650.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $13.10 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,112.50 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $108.96 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $53.71 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $37.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | Cash or cash equivalent | $16.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | Cash or cash equivalent | $8.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $85.53 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $517.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/11/2023 | BioXcel Therapeutics, Inc. | IGALMI (Drug) | Travel and Lodging | In-kind items and services | $306.28 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 255 | 256 | $331,531 | $35,831 |
| 2022 | 4 | 293 | 295 | $414,893 | $46,839 |
| 2021 | 4 | 310 | 316 | $438,844 | $50,506 |
| 2020 | 4 | 311 | 312 | $429,577 | $46,375 |
Total Patients
1,169
Total Services
1,179
Medicare Billing
$179,551
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 94 | 94 | $136,300 | $13,400 | 9.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 70 | 71 | $119,138 | $12,490 | 10.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 45 | 45 | $44,145 | $4,433 | 10.0% |
| 99236 | Initial hospital care with same-day admission and discharge with high level of medical decision making, per day, if using time, at least 85 minutes | Facility | 2023 | 14 | 14 | $20,972 | $2,295 | 10.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $8,240 | $2,181 | 26.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 16 | 16 | $2,736 | $1,032 | 37.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 156 | 157 | $227,650 | $24,795 | 10.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 89 | 89 | $149,342 | $18,332 | 12.3% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 18 | 18 | $17,658 | $1,864 | 10.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 30 | 31 | $20,243 | $1,848 | 9.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 167 | 170 | $246,500 | $27,621 | 11.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 83 | 86 | $144,308 | $18,113 | 12.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 27 | 27 | $26,487 | $2,799 | 10.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 33 | 33 | $21,549 | $1,972 | 9.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 166 | 167 | $242,150 | $24,950 | 10.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 78 | 78 | $130,884 | $16,168 | 12.4% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 39 | 39 | $38,259 | $3,775 | 9.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 28 | 28 | $18,284 | $1,482 | 8.1% |
About Dr. Pratik Mehta, MD
Dr. Pratik Mehta, MD is a Emergency Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2009. The National Provider Identifier (NPI) number assigned to this provider is 1841425824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pratik Mehta, MD has received a total of $74,561 in payments from pharmaceutical and medical device companies, with $650.00 received in 2024. These payments were reported across 171 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($59,925).
As a Medicare-enrolled provider, Mehta has provided services to 1,169 Medicare beneficiaries, totaling 1,179 services with total Medicare billing of $179,551. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Chicago, IL
- Active Since 05/20/2009
- Last Updated 05/20/2009
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1841425824
Products in Payments
- LOKELMA (Drug) $51,940
- IGALMI (Drug) $20,396
- BREZTRI (Drug) $1,685
- Kcentra (Biological) $111.70
- Endo GIA (Device) $110.76
- Cardiohelp (Device) $108.79
- ELIQUIS (Drug) $99.02
- DALVANCE (Drug) $55.05
- FARXIGA (Drug) $18.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Chicago
Dr. Barbara Bellar, M.d., J.d., Ma., Mph, M.D., J.D., MA., MPH
Emergency Medicine — Payments: $471,425
Emergency Medicine $471,425
Dr. Christopher Ross, Md, MD
Emergency Medicine — Payments: $338,465
Emergency Medicine $338,465
Janet Lin, M.d, M.D
Emergency Medicine — Payments: $118,644
Emergency Medicine $118,644
Michael Kurz
Emergency Medicine — Payments: $114,691
Emergency Medicine $114,691
Yanina Purim Shem Tov, M.d, M.D
Emergency Medicine — Payments: $90,220
Emergency Medicine $90,220
Dr. Robert Turelli, Md, MD
Emergency Medicine — Payments: $62,667
Emergency Medicine $62,667